Aclaris Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 42 U.S.-traded ETFs. ACRS has around 6.2M shares in the U.S. ETF market. The largest ETF holder of ACRS is the Vanguard Total Stock Market ETF (VTI), with approximately 1.79M shares. Investors may also find of interest that the ETF with the largest allocation to ACRS stock is ALPS Medical Breakthroughs ETF (SBIO), with a portfolio weight of 0.65%. On average, U.S. ETFs allocate 0.10% of ACRS to their portfolios.
Additionally, ACRS is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ACRS as a holding is the Invesco Nasdaq Biotechnology ETF (IBBQ), with a return of 5.69%.